Diadema Partners »

Ionis Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.5M 100k 65.42

More positions owned by Diadema Partners

Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)
Uniqure Nv SHS Put Option (QURE)
Regeneron Pharmaceuticals (REGN)
Viking Therapeutics (VKTX)
Bristol Myers Squibb (BMY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
BioMarin Pharmaceutical (BMRN)
Avidity Biosciences Ord (RNA)
Agios Pharmaceuticals Call Option (AGIO)
Ultragenyx Pharmaceutical (RARE)
Incyte Corporation Call Option (INCY)
Intellia Therapeutics Call Option (NTLA)
Vaxcyte (PCVX)
Eli Lilly & Co. Put Option (LLY)

View all positions for Diadema Partners

Top funds holding Ionis Pharmaceuticals

FMR
Vanguard Group
T. Rowe Price Investment Management
Capital World Investors
BlackRock
Wellington Management Company
Lombard Odier Asset Management
Bellevue Group
State Street Corporation
Deep Track Capital
Geode Capital Management
Tweedy, Browne Company
Citadel Advisors
Two Sigma Advisers
Deerfield Management Company

View all funds holding Ionis Pharmaceuticals